Douglas Janzen

Douglas Janzen

Chief Executive Officer at AEQUUS PHARMACEUTICALS INC.

Net worth: 3 766 $ as of 30/10/2026

58 year
Health Technology
Finance
Commercial Services

Profile

Mr. Douglas G.
Janzen is a Managing Director at Northview Ventures & Associates General Partnership, a Managing director&co founder at Northview LifeSciences, a Chairman, President & Chief Executive Officer at Aequus Pharmaceuticals, Inc. and a Chairman at Lexington Biosciences Holdings Corp.
He is on the Board of Directors at Transdermal Research Pharm Laboratories LLC, LifeSciences British Columbia, Alabaster Technologies, Inc. and Synaptive Technologies Ltd. Mr. Janzen was previously employed as a Chairman by Lexington Biosciences, Inc., an Independent Director by iCo Therapeutics, Inc., a President & Chief Business Officer by Bradmer Pharmaceuticals, Inc., an Independent Director by Neovasc, Inc., a President, Chief Executive Officer & Director by Correvio Pharma Corp., a Head of Research by Loewen, Ondaatje, McCutcheon Ltd., a Chairman by AbCellera Biologics, Inc., and an Analyst by Sprott Securities, Inc. He also served on the board at BioHEP Technologies Ltd., AmpHP, Inc., Aptamera, Inc., BIOTECanada, Medical Ventures Corp., Perimeter Medical Imaging AI, Inc., Perimeter Medical Imaging, Inc., Renaissance BioScience Corp., Sentinelle Medical ULC, Synaptive Medical, Inc. and Teal Valley Health, Inc. He received his undergraduate degree from the University of Saskatchewan and a graduate degree from the University of British Columbia.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/09/2025 12,553,800 ( 9.46% ) 3 766 $ 30/10/2026

Douglas Janzen active positions

CompaniesPositionStart
AEQUUS PHARMACEUTICALS INC. Chief Executive Officer 02/01/2013
Founder 31/03/2014
Founder 31/03/2014
Chairman 22/05/2017
Director/Board Member -
Synaptive Technologies Ltd.
Director/Board Member -
Director/Board Member 02/03/2013
Alabaster Technologies, Inc.
Director/Board Member -

Former positions of Douglas Janzen

CompaniesPositionEnd
REGISTERED PLAN PRIVATE INVESTMENTS INC. Chairman 30/11/2021
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Douglas Janzen's experience

Education of Douglas Janzen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

29

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies29

Finance

Health Technology

Electronic Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Commercial Services

Health Technology

Alabaster Technologies, Inc.

Health Technology

Health Technology

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Douglas Janzen